Literature DB >> 16336293

Opioid prescribing: an assessment using quality statements.

B G Jenkins1, P H R Tuffin, C L Choo, S A Schug.   

Abstract

OBJECTIVE: An audit of opioid prescribing in a large teaching hospital across all specialties was conducted to identify areas for improvement.
METHODS: Opioid medications prescribed for the entire patient admission were recorded and assessed using quality statements. RESULTS AND DISCUSSION: Of 334 patients reviewed 209 (62.6%) were prescribed an opioid. Poly-prescribing of 'when required' (p.r.n.) opioids was frequent with 107 (51.2%) patients having more than one 'p.r.n.' opioid. Dosing intervals were too long for 146 (69.8%) patients leaving them at risk of breakthrough pain. The intramuscular route was prescribed for 100 (47.8%) patients, and 49 (23.4%) of prescriptions had an inappropriate variety of administration routes.
CONCLUSION: Although the criteria for assessing opioid prescribing were stringent the prescribing was sub-optimal. This survey will form the basis for future quality initiatives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336293     DOI: 10.1111/j.1365-2710.2005.00690.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

1.  Design and validation of a medication assessment tool for cancer pain management.

Authors:  Gro Dahlseng Håkonsen; Steve Hudson; Thrina Loennechen
Journal:  Pharm World Sci       Date:  2006-11-21

2.  Implementation of an Opioid Stewardship Program to Promote Safer Opioid Prescribing.

Authors:  Lianping Ti; Tamara Mihic; Hannah James; Stephen Shalansky; Michael Legal; Seonaid Nolan
Journal:  Can J Hosp Pharm       Date:  2022-04-04

3.  Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002-2008.

Authors:  Elizabeth E Roughead; Susan J Semple
Journal:  Aust New Zealand Health Policy       Date:  2009-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.